13FPulse
中
BM

BMRN BIOMARIN PHARMACEUTICAL INC

2026Q2 · CUSIP 09061G101 · Sector: Healthcare & Biotech

Cooling

Net holder growth weakened from last quarter

Funds that own it
555
Institutions that reported holding it to the SEC
Net increase in holders
0
Last quarter 555 → now 555
How unusual is that
Below average
Stronger than only 36% of US stocks
What the filings say, in one paragraph

555 funds held BMRN at the end of 2026Q2. Buying has come off its highs, but funds are not exiting. On the business itself, revenue over the last 12 months was $3.4B(YoY +11.2%), the P/E is 171.7x, return on equity is 1.1%. BMRN has had 18 buying rushes in its history, and the price moved -6.0% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2013Q3: holders=277 2013Q4: holders=294 2014Q1: holders=302 2014Q2: holders=310 2014Q3: holders=309 2014Q4: holders=331 2015Q1: holders=362 2015Q2: holders=379 2015Q3: holders=385 2015Q4: holders=379 2016Q1: holders=378 2016Q2: holders=384 2016Q3: holders=411 2016Q4: holders=403 2017Q1: holders=405 2017Q2: holders=417 2017Q3: holders=399 2017Q4: holders=428 2018Q1: holders=423 2018Q2: holders=444 2018Q3: holders=452 2018Q4: holders=467 2019Q1: holders=479 2019Q2: holders=477 2019Q3: holders=437 2019Q4: holders=464 2020Q1: holders=494 2020Q2: holders=522 2020Q3: holders=489 2020Q4: holders=531 2021Q1: holders=527 2021Q2: holders=524 2021Q3: holders=504 2021Q4: holders=551 2022Q1: holders=553 2022Q2: holders=539 2022Q3: holders=550 2022Q4: holders=577 2023Q1: holders=550 2023Q2: holders=554 2023Q3: holders=516 2023Q4: holders=545 2024Q1: holders=552 2024Q2: holders=558 2024Q3: holders=551 2024Q4: holders=546 2025Q1: holders=587 2025Q2: holders=583 2025Q3: holders=577 2025Q4: holders=538 2026Q1: holders=555 2026Q2: holders=555 -47 -23.5 +0 +23.5 +47 249433617 13Q315Q116Q318Q119Q321Q122Q324Q125Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 18 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q1 Top 20% — —
2025Q1 Top 5% -3.5% -8.3%
2023Q4 Top 20% -12.6% +4.5%
2022Q4 Top 20% -14.0% -17.0%
2022Q3 Top 20% +26.2% +7.1%
2021Q4 Top 20% -15.7% +0.3%
2020Q4 Top 20% -8.2% -9.3%
2020Q2 Top 20% -35.1% -28.2%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
241
Change in large funds
+25
Total value they hold
$11.9B
Funds buying for the first time
89
Funds that sold out entirely
89
Price change that quarter
+34.8%
Funds holding puts (bearish)
7
Funds holding calls (bullish)
14

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
171.7
EPS (TTM)
$0.39
EPS YoY
-88.5%
Revenue (TTM)
$3.4B
Revenue YoY
+11.2%
Net margin
2.1%
ROE
1.1%
Debt ratio
46.1%
FCF (TTM)
$738M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -0.20 2021-12-31: EPS -0.31 2022-03-31: EPS 0.63 2022-06-30: EPS 0.15 2022-09-30: EPS -0.04 2022-12-31: EPS 0.01 2023-03-31: EPS 0.27 2023-06-30: EPS 0.29 2023-09-30: EPS 0.21 2023-12-31: EPS 0.10 2024-03-31: EPS 0.46 2024-06-30: EPS 0.55 2024-09-30: EPS 0.55 2024-12-31: EPS 0.65 2025-03-31: EPS 0.95 2025-06-30: EPS 1.23 2025-09-30: EPS -0.16 2025-12-31: EPS -0.22 2026-03-31: EPS 0.54 2026-06-30: EPS 0.23 0M 495M 990M $M -0.34 0.51 1.35 2016201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 73 15 192 370 20222023202420252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-150M95M340M 20162017201820192020202120222023202420252026
Latest quarter $200M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.